Effectiveness of interventions on physical symptoms of the study group Objects Symptom s Group drug Communication group Effectiveness of intervention (%) Before intervention (n=54) After intervention (n=54) Before intervention (n=53) After intervention (n=53) n% n% n% n% Pink nasal mucosa 29 53, 7 48 88, 9 29 54, 7 35 66, 0 44, 9 No mucus nasal cavity 9 16, 7 37 68, 5 9 17, 0 26 58, 9 63, 7 Normal middle conchae 29 53, 7 49 90, 7 33 62, 3 38 71, 7 53, 8 Normal inferior conchae 31 57, 4 45 83, 3 32 60, 4 34 64, 2 38, 8 After the intervention, in the Montelukast group, the prevalence of pink nasal mucosa increased from 53.7% to 88.9%; No mucus nasal cavity increased from 16.7% to 68.5%; The prevalence of normal middle conchae increased from 53.7% to 90.7%; The prevalence of normal inferior conchae increased from 57.4% to 83.3%.